Bright Minds Biosciences (DRUG) Shares Outstanding (2020 - 2026)

Bright Minds Biosciences' Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $7.0 million for Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 42.56% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (up 42.56% YoY) and the FY2025 annual result came in at $5.0 million, up 58.18% from the prior year.
• Shares Outstanding (Entity) was $7.0 million for Q1 2026 at Bright Minds Biosciences, up from $5.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $7.0 million in Q1 2026 and bottomed at $1.9 million in Q2 2022.
• A 5-year average of $3.6 million and a median of $3.2 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Peak annual rise in Shares Outstanding (Entity) reached 70.85% in 2022, while the deepest fall reached 1.01% in 2022.
• Bright Minds Biosciences' Shares Outstanding (Entity) stood at $2.6 million in 2022, then advanced by 6.81% to $2.8 million in 2023, then surged by 56.37% to $4.4 million in 2024, then gained by 26.09% to $5.6 million in 2025, then advanced by 25.65% to $7.0 million in 2026.
• Business Quant data shows DRUG's Shares Outstanding (Entity) at $7.0 million in Q1 2026, $5.6 million in Q4 2025, and $5.0 million in Q3 2025.